CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Biogen Inc 's Long Term Debt to Equity

BIIB's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




BIIB Long Term Debt to Equity (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Equity Change -19.89 % -23.21 % -12.82 % -9.3 % 2.36 %
Y / Y Long Term Debt Change 66.54 % 66.55 % 24.8 % -24.96 % -24.89 %
Long Term Debt to Equity MRQ 0.69 0.69 0.66 0.36 0.33
Overall Ranking # # # # #
Seq. Equity Change -0.54 % -4.82 % -9.95 % -6.01 % -4.66 %
Seq. Long Term Debt Change 0.02 % 0.02 % 66.46 % 0.02 % 0.02 %



Long Term Debt to Equity forth quarter 2020 Comment
Despite net new long-term borrowings of 0.02% Biogen Inc managed to improve Long Term Debt to Equity in the forth quarter 2020 to 0.69, above company's average Long Term Debt to Equity.

Within Biotechnology & Drugs industry in the forth quarter 2020, 56 other companies have achieved lower Long Term Debt to Equity than Biogen Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
Learn more about BIIB
Long Term Debt to Equity Ratio BIIB on the trailing twelve month basis
Long Term Debt to Equity forth quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 57
Healthcare Sector # 256
Overall Market # 1692


Long Term Debt to Equity Statistics
High Average Low
0.7 0.25 0.01
(Dec 31 2015)   (March 31, 2006)




Financial Statements
Biogen Inc 's Equity $ 10,686 Millions Visit BIIB's Balance sheet
Biogen Inc 's Long Term Debt $ 7,426 Millions Visit BIIB's Balance sheet
Source of BIIB's Sales Visit BIIB's Sales by Geography




Companies with similar Long Term Debt to Equity in the quarter endingDec 31 2020, within Biotechnology & Drugs Industry Long Term Debt to EquityDec 31 2020 MRQ Long Term DebtDec 31 2020 MRQ Equity
Avantor Inc   1.82 $ 4,867.500  Millions$ 2,674.300  Millions
Codiak Biosciences Inc   1.73 $ 25.167  Millions$ 14.567  Millions
Gilead Sciences Inc   1.57 $ 28,645.000  Millions$ 18,221.000  Millions
Reynolds Consumer Products Inc   1.37 $ 2,208.000  Millions$ 1,615.000  Millions
Neuronetics Inc   1.36 $ 34.620  Millions$ 25.493  Millions
Coherus Biosciences inc   1.34 $ 377.395  Millions$ 280.974  Millions
Aptevo Therapeutics Inc   1.21 $ 20.054  Millions$ 16.594  Millions
Nexien Biopharma Inc   1.16 $ 0.028  Millions$ 0.024  Millions
Adma Biologics Inc   1.05 $ 92.969  Millions$ 88.249  Millions
Evelo Biosciences Inc   0.99 $ 30.048  Millions$ 30.485  Millions
Aziyo Biologics Inc   0.86 $ 17.811  Millions$ 20.831  Millions
Acorda Therapeutics inc   0.70 $ 166.174  Millions$ 237.955  Millions
Biogen Inc   0.69 $ 7,426.200  Millions$ 10,686.100  Millions
Establishment Labs Holdings Inc   0.66 $ 49.832  Millions$ 74.961  Millions
Cure Pharmaceutical Holding Corp   0.66 $ 13.949  Millions$ 21.279  Millions
Eloxx Pharmaceuticals Inc   0.62 $ 6.376  Millions$ 10.230  Millions
Royalty Pharma Plc  0.59 $ 5,816.584  Millions$ 9,895.815  Millions
Emergent Biosolutions Inc   0.58 $ 841.000  Millions$ 1,447.000  Millions
Rubius Therapeutics inc   0.53 $ 74.944  Millions$ 141.560  Millions
Bionano Genomics Inc   0.47 $ 16.326  Millions$ 35.082  Millions
Allena Pharmaceuticals Inc   0.44 $ 9.853  Millions$ 22.569  Millions
Inhibrx Inc   0.39 $ 29.244  Millions$ 75.473  Millions
Axcella Health Inc   0.33 $ 25.222  Millions$ 75.381  Millions
Eiger Biopharmaceuticals Inc   0.33 $ 31.194  Millions$ 95.035  Millions
Unity Biotechnology Inc   0.30 $ 24.508  Millions$ 82.880  Millions
Aclaris Therapeutics Inc   0.28 $ 10.653  Millions$ 37.650  Millions
Neurocrine Biosciences Inc   0.28 $ 317.900  Millions$ 1,126.200  Millions
Strongbridge Biopharma plc  0.26 $ 17.114  Millions$ 65.605  Millions
Applied Genetic Technologies Corp  0.24 $ 9.844  Millions$ 41.522  Millions
Cyanotech Corp  0.23 $ 3.998  Millions$ 17.157  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FDBC's Profile

Stock Price

FDBC's Financials

Business Description

Fundamentals

Charts & Quotes

FDBC's News

Suppliers

FDBC's Competitors

Customers & Markets

Economic Indicators

FDBC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071